enviromantic / iStockphoto.com
With the two-year Brexit negotiations underway, life sciences companies and their lawyers will be watching closely to see how their businesses and IP will be affected. LSIPR reports with views from the UK, France and Germany.
The UK is aiming to leave the EU by March 2019. This means a lot of things are set to change in the next two years.
Since the UK government started its withdrawal process in late March, the UK and the rest of the EU life sciences sectors have been trying to secure their IP positions.
According to Alasdair Poore, partner at Mills & Reeve in the UK, one of the aspects which will change in the life sciences area is research.
You need a subscription to continue reading this content.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
Brexit, negotiations, Life Sciences, Alasdair Poore, Mills & Reeve, UPC,